Factbox-Who can get the newly approved Eisai and Biogen Alzheimer’s drug?
(Reuters) – The U.S. Food and Drug Administration on Friday approved Eisai Co Ltd and Biogen Inc’s Alzheimer’s drug lecanemab for the treatment of early forms of the fatal, brain-wasting…